How important is the pus culture obtained from epithelial growth factor receptor (EGFR) inhibitors’ associated rash?
- 29 October 2008
- journal article
- Published by Wiley in International Journal of Dermatology
- Vol. 47 (11), 1203-1204
- https://doi.org/10.1111/j.1365-4632.2008.03691.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Dermatologic side effects associated with the epidermal growth factor receptor inhibitorsJournal of the American Academy of Dermatology, 2006
- Erlotinib-associated skin reactions - case report and proposal for classificationBritish Journal of Dermatology, 2006
- EGFR-Targeted Therapy and Related Skin ToxicitySeminars in Oncology Nursing, 2006
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- HER1/EGFR Targeting: Refining the StrategyThe Oncologist, 2004
- Epidermal growth factor receptor expression, signal pathway, and inhibitors in non[ndash ]small cell lung cancerSeminars in Oncology, 2002